{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T18:22:15Z","timestamp":1768760535358,"version":"3.49.0"},"reference-count":43,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,10,8]],"date-time":"2009-10-08T00:00:00Z","timestamp":1254960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:sec><jats:label\/><jats:p><jats:bold>WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT<\/jats:bold><\/jats:p><jats:p>\u2022\u2003Clotrimazole troches are commonly used as prophylaxis for thrush that may develop in immunocompromised patients.<\/jats:p><jats:p>\u2022\u2003Conflicting data suggest that clotrimazole may induce or inhibit cytochrome P450 (CYP) 3A4.<\/jats:p><jats:p><jats:bold>WHAT THIS STUDY ADDS?<\/jats:bold><\/jats:p><jats:p>\u2022\u2003We have demonstrated that clotrimazole increased the area under the concentration\u2013time curve and decreased the apparent oral clearance of midazolam following oral administration without affecting the pharmacokinetic properties of midazolam after intravenous administration.<\/jats:p><jats:p>\u2022\u2003These data permit the suggestion that clotrimazole may cause clinically relevant changes in the pharmacokinetics or pharmacodynamics of concurrently administered oral CYP3A substrates that undergo significant first\u2010pass metabolism in this patient population.<\/jats:p><\/jats:sec><jats:sec><jats:title>AIMS<\/jats:title><jats:p>The aim of the study was to determine the effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam in the plasma.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>We conducted a randomized, open\u2010label, four\u2010way crossover study in 10 healthy volunteers. Each volunteer received oral midazolam 2\u2003mg or intravenous midazolam 0.025\u2003mg\u2003kg<jats:sup>\u22121<\/jats:sup>with and without oral clotrimazole troches 10\u2003mg taken three times daily for 5 days. Each study period was separated by 14 days. Serial blood samples were collected up to 24\u2003h after oral midazolam and 6\u2003h after intravenous midazolam. Plasma concentrations for midazolam and its metabolite 1\u2010hydroxymidazolam were measured and fitted to a noncompartmental model to estimate the pharmacokinetic parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Ten healthy volunteers aged 21\u201326 years provided written informed consent and were enrolled into the study. Clotrimazole decreased the apparent oral clearance of midazolam from 57 \u00b1 13\u2003l\u2003h<jats:sup>\u22121<\/jats:sup>[95% confidence interval 48, 66] to 36 \u00b1 9.8\u2003l\u2003h<jats:sup>\u22121<\/jats:sup>(95% confidence interval 29, 43) (<jats:italic>P<\/jats:italic>= 0.003). These changes were accompanied by a decrease in the area under the concentration\u2013time curve (mean difference 22\u2003\u00b5g\u2003h<jats:sup>\u22121<\/jats:sup>\u2003l<jats:sup>\u22121<\/jats:sup>,<jats:italic>P<\/jats:italic>= 0.001) and bioavailability (mean difference 0.21,<jats:italic>P<\/jats:italic>= NS). There were no significant differences in the systemic clearance of midazolam with or without clotrimazole troches.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Oral clotrimazole troches decreased the apparent oral clearance of midazolam; no significant differences in the systemic clearance of midazolam were found.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2125.2009.03559.x","type":"journal-article","created":{"date-parts":[[2009,10,8]],"date-time":"2009-10-08T10:56:33Z","timestamp":1254999393000},"page":"160-166","source":"Crossref","is-referenced-by-count":26,"title":["Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam"],"prefix":"10.1111","volume":"69","author":[{"given":"Stacy S.","family":"Shord","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingtak\u2010Neander","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph R.","family":"Camp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva M.","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun\u2010Young","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Molokie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles L.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,1,21]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03400180087032"},{"key":"e_1_2_7_3_2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archinte.1984.00350140096014","article-title":"Prophylaxis of oral candidiasis with clotrimazole troches","volume":"144","author":"Owens NJ","year":"1984","journal-title":"Arch Intern Med"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(92)90345-Q"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.10.056"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.5.540"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200038020-00002"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270007309703"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.28.1805"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L330"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0350-0"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.02.022"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802644209"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2004.01.005"},{"key":"e_1_2_7_15_2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0090-9556(24)15255-5","article-title":"Effect of inhibitor depletion on inhibitory potency: tight binding inhibition of CYP3A by clotrimazole","volume":"27","author":"Gibbs MA","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.7.795"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199112000-00029"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.2001.150203.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0026-895X(25)08713-9","article-title":"Modulators and substrates of P\u2010glycoprotein and cytochrome P4503A coordinately up\u2010regulate these proteins in human colon carcinoma cells","volume":"49","author":"Schuetz EG","year":"1996","journal-title":"Mol Pharmacol"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.3.314"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(97)00043-4"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.58.2.361"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/026119290303100307"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2008.01739.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02689.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02613.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.7547\/87507315-92-8-471"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199712000-00001"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70029-9"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(95)00286-6"},{"key":"e_1_2_7_31_2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0378-4347(00)00573-9","article-title":"Liquid chromatographic determination of ketoconazole, a potent inhibitor of CYP3A4\u2010mediated metabolism","volume":"753","author":"De Bruijn P","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.129068"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00187-5"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90146-1"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00562804"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-200201000-00007"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70009-3"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.60"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050223"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.1999.430504.x"},{"key":"e_1_2_7_41_2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0090-9556(24)15255-5","article-title":"Effect of inhibitor depletion on inhibitory potency: tight binding inhibition of CYP3A by clotrimazole","volume":"27","author":"Gibbs MA","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.23.669"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.6.1634"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1995.tb04540.x"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.2009.03559.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.2009.03559.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T16:45:12Z","timestamp":1739378712000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.2009.03559.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,21]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1365-2125.2009.03559.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.2009.03559.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,21]]}}}